CustomBiotech mRNA Portfolio Products

Efficient mRNA production requires a reliable foundation of high-purity raw materials that bridge the gap between discovery and large-scale manufacturing. Navigating the transition to clinical phases demands enzymes and ribonucleotides that meet rigorous quality standards, ensuring consistency and safety in every batch. This selection of fit-for-purpose reagents includes GMP-grade polymerases, capping enzymes, and highly concentrated NTPs designed to streamline complex synthesis workflows.

Key components like T7 and SP6 RNA polymerases, alongside specialized modifiers such as Guanylyltransferase and Methyltransferase, provide the precision necessary for high-yield transcription and effective mRNA stabilization. Every product is strictly evaluated for residual contaminants, including RNase and DNase activity, bioburden, and endotoxins, to maintain the integrity of the final therapeutic. Access the complete portfolio to find the exact technical specifications and pack sizes needed to scale your mRNA platform with confidence.